Walser Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Walser Wealth Management's ABBV Position: Q3 2026 in Review
Walser Wealth Management increased its AbbVie (ABBV) stake by 13% in Q3 2026, buying an estimated $69.7K and bringing the position to 2,305 shares worth $603K. The position accounts for 0.24% of the portfolio, ranked #101.
Walser Wealth Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Walser Wealth Management held 2,305 shares of AbbVie worth $603K as of Q3 2026.
- Walser Wealth Management bought 272 AbbVie shares in Q3 2026, an estimated $69.7K.
- AbbVie made up 0.24% of Walser Wealth Management's portfolio in Q3 2026, its #101 holding.
- Walser Wealth Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Walser Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.